AGENDA
BIOS
IMPACT TIMELINE
AGENDA
BIOS
IMPACT TIMELINE
Extraordinary Evolutions in Electrophysiology (EP)
Advancements in medicine have enabled electrophysiologists to diagnose and treat heart rhythm abnormalities like never before. From the first pacemaker to the latest cardiac technology, follow us through the years and see what these innovations have made possible for you—and your patients.
1957
1957
In the middle of a decade that already provided a series of technological breakthroughs, another “first” included THE FIRST MYOCARDIAL WIRE IMPLANT.
1957
In the middle of a decade that already provided a series of technological breakthroughs, another “first” included THE FIRST MYOCARDIAL WIRE IMPLANT.
1958
1958
Building upon earlier successes, the wearable pacemaker gets a major upgrade as the first fully implantable pacemaker makes its debut.
1958
Building upon earlier successes, the wearable pacemaker gets a major upgrade as the first fully implantable pacemaker makes its debut.
1972

THE 1ST LITHIUM-
POWERED PACEMAKER.

is implanted, providing greater reliability and improving countless patients' lives for years to come.
1980
1980
While clinical experience with automatic
internal defibrillation is now widespread—used in treating over 65,000 patients—the first implantation occurred in 1980 at Johns Hopkins.
1980
While clinical experience with automatic
internal defibrillation is now widespread—used in treating over 65,000 patients—the first implantation occurred in 1980 at Johns Hopkins.
1985
1985
With the ability to monitor cardiac rhythm and recognize potentially life-threatening arrhythmias, THE AICD is granted approval for general use by the Food and Drug Administration (FDA).
1985
With the ability to monitor cardiac rhythm and recognize potentially life-threatening arrhythmias, THE AICD is granted approval for general use by the Food and Drug Administration (FDA).
1993
1993


Long-term reliability and failure rates are an
ongoing challenge, so it was an important milestone

ENDOTAK - THE FIRST
TRANSVENOUS ENDOCARDIAL
DEFRIBILLATING LEAD - GETS FDA
APPROVAL.
1995
1995


GUIDANT FIRST PECTORAL
PLACEMENT BIPHASIC IMPLANTABLE
CARDIO-DEFIBRILLATOR (ICD)

is approved, along with the MINI and MDT Jewel providing
thinner, lighter options.
1980
1996
The MADIT TRIAL (Multicenter Automatic Defibrillator Trial) studied the long-term benefit of SCD prevention by using an implantable cardioverter-defibrillator—which ultimately improved survival in a high-risk group.
1996
The MADIT TRIAL (Multicenter Automatic Defibrillator Trial) studied the long-term benefit of SCD prevention by using an implantable cardioverter-defibrillator—which ultimately improved survival in a high-risk group.
1997

Another "first"— an advancement that helped correct life threatening heart rhythm disorders.
The VENTAK AV, the first dual-chamber ICD, is approved by the FDA and hits the U.S. market.
 2002
THE RESULTS FROM THE MADIT II (MULTICENTER AUTOMATIC DEFIBRILLATOR TRIAL)
prompted a new indication for AICDs. Patients with a history of an MI and are identified as being at risk of SCD are now indicated for a device implanted before suffering their first SCD.
2002
THE CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER (CRT-P) IS FDA APPROVED
Delivering small electrical impulses, it ensures the left and right ventricles contract at the same time, helping the heart pump more efficiently.
2002
2005
2005
Sudden cardiac death (SCD) is the leading cause of death in the United States. The SCD-HeFT trial helped demonstrate that ICDs reduced mortality for high-risk patients, compared to conventional therapy.
2005
Sudden cardiac death (SCD) is the leading cause of death in the United States. The SCD-HeFT trial helped demonstrate that ICDs reduced mortality for high-risk patients, compared to conventional therapy.
2012

THE FDA GRANTS APPROVAL FOR OUR S-ICD® SYSTEM
the world's first commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).
2012
2012
THE NANOSTIM™ PACEMAKER
IS FIRST IMPLANTED.

Designed to be placed directly in the heart, it's a non-surgical solution without the visible scar and leads required in conventional pacemakers.
2012
THE NANOSTIM™ PACEMAKER
IS FIRST IMPLANTED.

Designed to be placed directly in the heart, it's a non-surgical solution without the visible scar and leads required in conventional pacemakers.
2018
2015
Communication between a subcutaneous implantable cardioverter-defibrillator (S-ICD) and a leadless pacemaker (LP) is demonstrated in preclinical models, proving the feasibility of the LP design and modular system.
2015
Communication between a subcutaneous implantable cardioverter-defibrillator (S-ICD) and a leadless pacemaker (LP) is demonstrated in preclinical models, proving the feasibility of the LP design and modular system.
Top